Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kabelitz

Showing results (61-70 of 211) with videos related to

Pageof 22
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1993
Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cellsS Wesselborg, O Janssen, D Kabelitz
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1998
Monocyte-dependent death of freshly isolated T lymphocytes: induction by phorbolester and mitogens and differential effects of catalaseD Wesch, S Marx, D Kabelitz
Immunology Letters|February 1, 1989
Esculetin inhibits T cell activation without suppressing IL-2 production or IL-2 receptor expressionD Kabelitz, K H Al-Gorany
Cellular Immunology|April 15, 1987
Specificity repertoire of splenic Lyt-2+/F23+ cytotoxic lymphocyte precursors from B6 miceJ Reimann, A Bellan, D Kabelitz
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1987
Antigen-presenting T cells. I. Class I alloantigen (bm1)-bearing T lymphoblasts efficiently stimulate a primary clonal response of Lyt-2+ cytotoxic lymphocyte precursors of B6 originJ Reimann, A Bellan, D Kabelitz
Scandinavian Journal of Immunology|June 30, 2015
Lysosome-Related Effector Vesicles in T Lymphocytes and NK CellsM Lettau, D Kabelitz, O Janssen
Journal of Immunological Methods|March 16, 1988
Use of OKT3 hybridoma cells to clonally activate CD3+ human T lymphocytesD Kabelitz, O Janssen, C Brucker
Immunobiology|September 1, 1987
B cell maturation in chronic lymphocytic leukemia. II. Clonal heterogeneity in the response to various B cell activators and recombinant cytokines (rIFN-gamma, rIFN-alpha, rIL2)K Pfeffer, C Nerl, D Kabelitz
Cellular Immunology|December 26, 2001
Differentiation of resting human peripheral blood gamma delta T cells toward Th1- or Th2-phenotypeD Wesch, A Glatzel, D Kabelitz
Current Medicinal Chemistry|November 18, 2011
Aminobisphosphonates and Toll-like receptor ligands: recruiting Vγ9Vδ2 T cells for the treatment of hematologic malignancyS Kalyan, D Wesch, D Kabelitz
Pageof 22

Showing results (61-70 of 211) with videos related to

Sort By:
Pageof 22
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1993
Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cellsS Wesselborg, O Janssen, D Kabelitz
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1998
Monocyte-dependent death of freshly isolated T lymphocytes: induction by phorbolester and mitogens and differential effects of catalaseD Wesch, S Marx, D Kabelitz
Immunology Letters|February 1, 1989
Esculetin inhibits T cell activation without suppressing IL-2 production or IL-2 receptor expressionD Kabelitz, K H Al-Gorany
Cellular Immunology|April 15, 1987
Specificity repertoire of splenic Lyt-2+/F23+ cytotoxic lymphocyte precursors from B6 miceJ Reimann, A Bellan, D Kabelitz
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1987
Antigen-presenting T cells. I. Class I alloantigen (bm1)-bearing T lymphoblasts efficiently stimulate a primary clonal response of Lyt-2+ cytotoxic lymphocyte precursors of B6 originJ Reimann, A Bellan, D Kabelitz
Scandinavian Journal of Immunology|June 30, 2015
Lysosome-Related Effector Vesicles in T Lymphocytes and NK CellsM Lettau, D Kabelitz, O Janssen
Journal of Immunological Methods|March 16, 1988
Use of OKT3 hybridoma cells to clonally activate CD3+ human T lymphocytesD Kabelitz, O Janssen, C Brucker
Immunobiology|September 1, 1987
B cell maturation in chronic lymphocytic leukemia. II. Clonal heterogeneity in the response to various B cell activators and recombinant cytokines (rIFN-gamma, rIFN-alpha, rIL2)K Pfeffer, C Nerl, D Kabelitz
Cellular Immunology|December 26, 2001
Differentiation of resting human peripheral blood gamma delta T cells toward Th1- or Th2-phenotypeD Wesch, A Glatzel, D Kabelitz
Current Medicinal Chemistry|November 18, 2011
Aminobisphosphonates and Toll-like receptor ligands: recruiting Vγ9Vδ2 T cells for the treatment of hematologic malignancyS Kalyan, D Wesch, D Kabelitz
Pageof 22